{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-030517","form_type":"8-K","ticker":"GYRE","cik":"0001124105","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.000251+00:00","generated_at":"2026-06-13T20:36:16.330179+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Catalyst creates super-voting Series Y Preferred to ensure reverse stock split approval","bullets":["Board declared dividend of one one-thousandth of a share of Series Y Preferred for each common share, record date June 30, 2023.","Each one-thousandth of a share of Series Y Preferred entitles holder to 250 votes, but only on a reverse stock split proposal.","Series Y Preferred cannot be transferred separately from common shares, and will be redeemed at $0.001 per whole share after the vote.","Series Y Preferred ranks senior to common but junior to Series X Preferred and CVRs; no dividend rights, only liquidation preference of $0.001 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-030517","json":"https://secwatch.observer/filing/0001140361-23-030517.json","markdown":"https://secwatch.observer/filing/0001140361-23-030517.md","text":"https://secwatch.observer/filing/0001140361-23-030517.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123030517/0001140361-23-030517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123030517/brhc20054638_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:36:16.330179+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4aa29d34d2fe0d181efa09186d28ece8773598b3","claim":"GYRE THERAPEUTICS, INC.: Filed a Certificate of Designation for Series Y Preferred Stock, setting forth rights, preferences, and limitations in connection with a Reverse Stock Split amendment to the Certificate of Incorporation (effective 2023-06-20).","evidence_excerpt":"The Company has filed a certificate of designation with respect to the Series Y Preferred Stock (the “Certificate of Designation”) that sets forth the rights, preferences and limitations of the Series Y Preferred Stock","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123030517/0001140361-23-030517-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-06-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}